Literature DB >> 32843206

Obesity and Coronary Heart Disease: Epidemiology, Pathology, and Coronary Artery Imaging.

Natraj Katta, Troy Loethen, Carl J Lavie, Martin A Alpert.   

Abstract

Overweight and obesity contribute to the development of cardiovascular disease (CVD) in general and coronary heart disease (CHD) in particular in part by their association with traditional and nontraditional CVD risk factors. Obesity is also considered to be an independent risk factor for CVD. The metabolic syndrome, of which central obesity is an important component, is strongly associated with CVD including CHD. There is abundant epidemiologic evidence of an association between both overweight and obesity and CHD. Evidence from postmortem studies and studies involving coronary artery imaging is less persuasive. Recent studies suggest the presence of an obesity paradox with respect to mortality in persons with established CHD. Physical activity and preserved cardiorespiratory fitness attenuate the adverse effects of obesity on CVD events. Information concerning the effect of intentional weight loss on CVD outcomes in overweight and obese persons is limited.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32843206     DOI: 10.1016/j.cpcardiol.2020.100655

Source DB:  PubMed          Journal:  Curr Probl Cardiol        ISSN: 0146-2806            Impact factor:   5.200


  18 in total

1.  Complexities and complications of extreme obesity.

Authors:  Haval Ali; Udit Naik; Michelle McDonald; Mohammad Almosa; Karen Horn; Alexis Staines; Louis Maximilian Buja
Journal:  Autops Case Rep       Date:  2022-10-05

2.  Jinlida Granules Reduce Obesity in db/db Mice by Activating Beige Adipocytes.

Authors:  Hong-Ru Zhou; Tong-Xing Wang; Yuan-Yuan Hao; Yun-Long Hou; Cong Wei; Bing Yao; Xuan Wu; Dan Huang; Hui Zhang; Yi-Ling Wu
Journal:  Biomed Res Int       Date:  2022-05-19       Impact factor: 3.246

3.  Complementary and alternative therapies for stable angina pectoris of coronary heart disease: A protocol for systematic review and network meta-analysis.

Authors:  Guanyu Wang; Feiran Li; Xu Hou
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

4.  The efficacy of a short one-on-one nursing intervention in people with coronary heart disease: A randomized controlled trial protocol.

Authors:  Wen Xia; Ting Liu; Jie Lei
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

5.  Usefulness of estimated pulse wave velocity for identifying prevalent coronary heart disease: findings from a general Chinese population.

Authors:  Xiao-Wu He; Jieun Park; Wen-Sheng Huang; Li-Hua Leng; Yan Yu; Yi-Bin Pei; Gao Zhu; Shaohui Wu
Journal:  BMC Cardiovasc Disord       Date:  2022-01-12       Impact factor: 2.298

6.  Vascular Tissue Specific miRNA Profiles Reveal Novel Correlations with Risk Factors in Coronary Artery Disease.

Authors:  Katrīna D Neiburga; Baiba Vilne; Sabine Bauer; Dario Bongiovanni; Tilman Ziegler; Mark Lachmann; Simon Wengert; Johann S Hawe; Ulrich Güldener; Annie M Westerlund; Ling Li; Shichao Pang; Chuhua Yang; Kathrin Saar; Norbert Huebner; Lars Maegdefessel; Rüdiger Lange; Markus Krane; Heribert Schunkert; Moritz von Scheidt
Journal:  Biomolecules       Date:  2021-11-12

7.  Relation of circulating lncRNA GAS5 and miR-21 with biochemical indexes, stenosis severity, and inflammatory cytokines in coronary heart disease patients.

Authors:  Yan Jiang; Tian Du
Journal:  J Clin Lab Anal       Date:  2022-01-08       Impact factor: 2.352

8.  Protective effect of liquiritin on coronary heart disease through regulating the proliferation of human vascular smooth muscle cells via upregulation of sirtuin1.

Authors:  Liang Yuan; Dajie Wang; Chunyang Wu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

9.  Relationship of body fat and left ventricular hypertrophy with the risk of all-cause death in patients with coronary artery disease.

Authors:  Bao-Tao Huang; Lu Yang; Bo-Sen Yang; Fang-Yang Huang; Qian-Feng Xiao; Xiao-Bo Pu; Yong Peng; Mao Chen
Journal:  J Geriatr Cardiol       Date:  2022-03-28       Impact factor: 3.327

Review 10.  Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations.

Authors:  Li-Chan Tao; Jia-Ni Xu; Ting-Ting Wang; Fei Hua; Jian-Jun Li
Journal:  Cardiovasc Diabetol       Date:  2022-05-06       Impact factor: 8.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.